Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Abuse-Deterrence Among New GDUFA Regulatory Science Priorities

Oct 03 2014

• By Derrick Gingery

Related Content

Opioid Market Snapshot: No Pain, No Gain For Abuse-Deterrence Claims

Mar 24 2014

Drug Shortage Prevention Could Be Funded Through GDUFA

May 26 2014

<em>OxyContin</em>’s Abuse-Deterrent Claims Strong, But Stronger Claims Possible

Apr 22 2013

Related Companies

Purdue Pharma L.P.

Pfizer Inc.

Zogenix, Inc.

Additional Topics

United States Drug Approval Standards Post Market Regulation & Studies BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window